Safety of resuming anti-PD-1 in patients with immune-related adverse events (irAEs) during combined anti-CTLA-4 and anti-PD1 in metastatic melanoma
Megan H. Pollack(Vanderbilt University), Allison Betof Warner(Memorial Sloan Kettering Cancer Center), Helen Clare Dearden(The University of Sydney), K. Rapazzo(Vanderbilt University), Ian Valentine(Moffitt Cancer Center), Andrew S. Brohl(Moffitt Cancer Center), Kristin Kathleen Ancell(Vanderbilt University), Georgina V. Long(The University of Sydney), Alexander M. Menzies(The University of Sydney), Zeynep Eroglu(Moffitt Cancer Center), Douglas B. Johnson(Vanderbilt University), Alexander N. Shoushtari(Memorial Sloan Kettering Cancer Center)
Cited by 389Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis